Noveris Health Sciences Inc., a biotechnology company, engages in developing and commercializing solutions for treating mental health problems and enhancing vitality. The company primarily focuses on treating nicotine addiction and post-tra…
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
News 2026-07-14
News release - English.pdf
Transactions 2026-06-11 Financing
Report of exempt distribution (45-106F1) (amended).pdf
News 2026-06-05
Noveris Health Sciences Provides Corporate Update
News release - English.pdf
Results 2026-05-28
Interim MD&A - English.pdf
Results 2026-05-28
Interim financial statements/report – English.pdf
Ownership 2026-05-20
Bartch, David Joshua sold +$4.6M
Insider trading – 2026-05-20
1 insider · −$4.6M net
Results 2026-05-01
Annual MD&A - English.pdf
Results 2026-05-01
Audited annual financial statements – English.pdf
Transactions 2026-04-29 M&A
NOVERIS HEALTH SCIENCES PROVIDES CORPORATE UPDATE, AND ANNOUNCES AGREEMENT FOR ACQUISITION OF STEM CELL DISTRIBUTION BUSINESS
News release - English.pdf
News 2026-04-22
NOVERIS HEALTH SCIENCES INC. ANNOUNCES SIGNING OF MARKET MAKING ADVISORY AGREEMENT WITH DS MARKET SOLUTIONS INC.
News release - English.pdf
News 2026-04-20
Noveris Health Sciences Inc. Provides Clarifying News Release Regarding Life Offering and Other Disclosure
News release - English.pdf
Transactions 2026-03-30 Financing
Report of exempt distribution (45-106F1).pdf
Transactions 2026-03-23 Financing
Noveris Health Sciences Inc. Closes Non-Brokered Private Placement
Material change report - English.pdf
News 2026-03-23
Early warning report.pdf
Transactions 2026-03-19 Financing
NOVERIS ANNOUNCES CLOSING OF LIFE OFFERING
News release - English.pdf
News 2026-03-14
Noveris Health Sciences Launches Investor Website and Engages Fairfax Partners Inc. for Investor Relations and Digital Marketing Services
News release - English.pdf
News 2026-03-12
Offering document - English.pdf
Transactions 2026-03-12 Financing
NOVERIS ANNOUNCES LIFE OFFERING
News release - English.pdf
Ownership 2026-03-07
NOVERIS ANNOUNCES CONVERSION OF DEBENTURES; FILING OF EARLY WARNING REPORTS BY JJK HOLDINGS LTD. AND JOSHUA BARTCH
News release - English.pdf
News 2026-02-28
Early warning report.pdf
News 2026-02-27
Early warning report.pdf
Ownership 2026-02-27
JJK HOLDINGS LTD. ACQUIRES $7,878,792 CONVERTIBLE DEBENTURE OF NOVERIS HEALTH SCIENCES INC.; FILING OF EARLY WARNING REPORTS BY JJK HOLDINGS LTD. AND PIONEER GARAGE LIMITED
News release - English.pdf
Transactions 2026-02-18 Financing
Noveris Health Sciences Inc. Provides Supplemental Disclosure Regarding Previously Announced Convertible Debenture Issuances
News release - English.pdf
News 2026-02-06
Notice.pdf
Transactions 2026-02-06 M&A
Noveris Health Sciences Inc. announces name change from Mydecine Innovation Group Inc.
Material change report - English.pdf
News 2026-02-02
Certificate and articles of change of name.pdf
News 2025-11-26
Early warning report.pdf
Ownership 2025-11-26
EARLY WARNING NEWS RELEASE REGARDING DEBT SETTLEMENT BY RAY VAN EMPEL IN MYDECINE INNOVATIONS GROUP INC.
Press release - English.pdf
Results 2025-11-17 Financials
Interim MD&A - English.pdf
Results 2025-11-17 Financials
Interim financial statements/report – English.pdf
News 2025-10-22
Report of exempt distribution (45-106F1).pdf
News 2025-10-22
Material change report - English.pdf
News 2025-10-21
Other securityholders documents - English.pdf
News 2025-10-21
Other.pdf
News 2025-10-21
Other securityholders documents - English.pdf
News 2025-10-21
Other securityholders documents - English.pdf
News 2025-10-21
Other securityholders documents - English.pdf
News 2025-10-21
Cover letter.pdf
News 2025-10-21
Material change report - English.pdf
News 2025-10-17
Early warning report.pdf
News 2025-10-17
Press release - English.pdf
News 2025-10-14
News release - English.pdf
News 2025-10-06
News release - English.pdf
News 2025-08-29
Other.pdf
News 2025-08-29
Other.pdf
News 2025-08-29
Other.pdf
News 2025-08-12
Statement of executive compensation (form 51-102F6V) - English.pdf
Results 2025-07-22 Financials
Interim MD&A - English.pdf
Results 2025-07-22 Financials
Interim financial statements/report – English.pdf